Parenteral drugs are the second most preferred
type of drugs after oral solid dosage forms and also holds second
largest market share in terms of revenue in overall pharmaceutical
market. Various benefits such as ease in administration, better
patient compliance and 100% bioavailability are the few important
factors that are expected to favor growth of the prefilled syringes
market over the forecast period (2016–2024). Prefilled syringes
segment is the one of the most important of the parenteral products
market. However, volume sales in the market is rather low as it is a
fairly novel product. The market is expected to gain traction over
the forecast period, with increasing number of products and growing
awareness among the populace about the benefits of the product. There
are various factors such as ease in administration and minimum
contact with the exposed environment that are expected to favor
growth of the prefilled syringes market in the near future. Use of
syringes with prefilled drugs would be especially useful in emergency
situations. According to Drug Development & Delivery, around 3.5
billion of prefilled syringes are produced each year and the existing
numbers are expected to grow by the rate of around 9.0 – 10%
annually.
Fill the form for an exclusive sample of this
report @
https://www.coherentmarketinsights.com/insight/request-sample/162
Prefilled Syringes market taxonomy:
By Application
Monoclonal Antibodies
Vaccines
Others
By Material Type
Polymer
PVC
Cyclo-olefin Polymer(COP)
Glass
By Design
Single Chambered
Dual Chambered
Multi-Chambered
Rising demand for biologics and
self-injection products to augment market growth
A large number of newly approved biologics and
drugs demand for PFS delivery devices for the subcutaneous (SC)
self-injection of biopharmaceuticals. Also, the need for simpler
self-injection procedures and improved patient compliance for auto
injectors, large-volume patch injectors and pens is on the rise. This
in turn is expected to favor growth of the prefilled syringes market
over the forecast period (2016–2024). Patient exposure towards the
routine injection can affect patient compliance, as it can cause
significant discomfort to the user. Introduction of large volume
biologics though, have helped rise in adoption rate of prefilled
syringes. This in turn is expected to favor the market over the
forecast period. Some factors such as growth in adoption of
injectable drugs, success and growth of biologics, increased global
vaccination, increased drug self-administration trend, technological
advancements in the manufacture of PFS, and development of advanced
PFS would further augment market growth.
Rise in number of applications is to favor
the expansion of global prefilled syringes market:
Prefilled syringes market is expanding rapidly
globally due to its various applications in overall healthcare
sector. Nowadays, PFS manufacturing companies are focused on
promoting use of the product in various application especially in
homecare settings, which further is projected to favor increase in
customer base in various regions. Furthermore, manufacturers are
working towards developing PFS vaccines to help in indications such
as various infectious disease and cancer. PFS are also being
efficiently used in emergency medical services and in emergency
section of hospitals. According to Frederick Furness Publishing Ltd,
around 70% of atropine syringes prepared by the hospital staff are
pre-filled and can be immediately used in emergency conditions.
Request to view table of content @
https://www.coherentmarketinsights.com/ongoing-insight/toc/162
Highly consolidated market is expected to
favor the sales revenue of prefilled syringes market:
There are around 20 pharmaceutical companies that
are involved in manufacturing and marketing of prefilled syringes as
preferred delivery device of around 50 injectable drugs and vaccines,
which contributes significantly to the sales revenue of these
players. Furthermore, there are few recent acquisitions by the big
brands in market of prefilled syringes such as in 2012, Becton
Dickinson and Company acquired Safety Syringes, Inc., which is
further expected to favor the company’s syringes manufacturing
efficiency and increase its product portfolio. Key players operating
in the prefilled syringes market include Becton Dickinson & Co.,
Gerresheimer, Medtronic, Baxter International, SCHOTT AG, West
Pharmaceuticals, Vetter International, Unilife Corporation, Stevanato
Group, and Terumo Corporation
About Us:
Coherent Market Insights is a prominent market
research and consulting firm offering action-ready syndicated
research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
No comments:
Post a Comment